Peptide record

TPDB00548

ACE inhibitor ACE inhibitors Antihypertensive Antioxidant standard
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB00548
ACE inhibitor
ACE inhibitors Antihypertensive Antioxidant
Cardiometabolic peptides Functional / health-promoting peptides
Peptipedia AHTPDB AHTpin AnOxPePred - 1.0 AODB AoXpDb Multi-AOP
standard
No
A 5-aa standard-residue multi-activity (ACE inhibitors, Antihypertensive, and Antioxidant) peptide sequence curated from Peptipedia, AHTPDB, AHTpin, and other sources, with an available 3D structural model.
Sequence
FYPEL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C34H45N5O9
ARNDCQGHIKMSTWV
ELFPY
667.76
3.29
0
1
3
-1
-0.19
0.040
78.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
1490
2.23
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
1
E
0
Q
0
G
0
H
0
I
1
L
0
K
0
M
1
F
1
P
0
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 0 M: 0 F: 1 P: 1 S: 0 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
5 reviewed residue count
C34H45N5O9 sequence-only estimate (linear, free termini)
667.76 sequence-only estimate (linear, free termini)
3.29 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
-0.19 sequence-only estimate (linear, free termini)
0.040 sequence-only estimate (linear, free termini)
667.7474 Activity
667.3206 Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
81.62 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Contreras M. M., Sánchez-Infantes D., Sevilla M. A., Recio I., Amigo L.
Resistance of casein-derived bioactive peptides to simulated gastrointestinal digestión. Int. Dairy J., 32, 71–78, 2013
2013
Journal

Other

5
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3[C@@H](CCC3)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O InChI=1S/C34H45N5O9/c1-20(2)17-27(34(47)48)38-31(44)25(14-15-29(41)42)36-32(45)28-9-6-16-39(28)33(46)26(19-22-10-12-23(40)13-11-22)37-30(43)24(35)18-21-7-4-3-5-8-21/h3-5,7-8,10-13,20,24-28,40H,6,9,14-19,35H2,1-2H3,(H,36,45)(H,37,43)(H,38,44)(H,41,42)(H,47,48)/t24-,25-,26-,27-,28-/m0/s1 InChIKey=SNAOQMOLGPCGFY-XLIKFSOKSA-N Antioxidative peptide according to the BIOPEP-UWM database of bioactive peptides (ID 8141) the EROP-Moscow database the MBPDB database
Evidence 2 Activity

Activity

IC50
Antihypertensive
81.62 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB
Contreras M. M., Sánchez-Infantes D., Sevilla M. A., Recio I., Amigo L.
Resistance of casein-derived bioactive peptides to simulated gastrointestinal digestión. Int. Dairy J., 32, 71–78, 2013
2013
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
5
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3[C@@H](CCC3)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O InChI=1S/C34H45N5O9/c1-20(2)17-27(34(47)48)38-31(44)25(14-15-29(41)42)36-32(45)28-9-6-16-39(28)33(46)26(19-22-10-12-23(40)13-11-22)37-30(43)24(35)18-21-7-4-3-5-8-21/h3-5,7-8,10-13,20,24-28,40H,6,9,14-19,35H2,1-2H3,(H,36,45)(H,37,43)(H,38,44)(H,41,42)(H,47,48)/t24-,25-,26-,27-,28-/m0/s1 InChIKey=SNAOQMOLGPCGFY-XLIKFSOKSA-N Antioxidative peptide according to the BIOPEP-UWM database of bioactive peptides (ID 8141) the EROP-Moscow database the MBPDB database
Evidence 3 Activity

Activity

Antioxidative activity
Antioxidant

Source & Reference

AODB AoXpDb
DFBP
Additional Detail Fields 1 fields
5